On November 18, Gelonghui reported that Goldman Sachs released a report following china life insurance's announcement of its third-quarter results, raising the company's earnings forecast for this year by 19%, mainly due to better-than-expected investment performance in the third quarter, and made slight adjustments to the earnings forecasts for the next two years by 1% to 2%. Therefore, Goldman Sachs slightly raised the target price for china life insurance from HKD 18 to HKD 19, maintaining a "buy" rating on its listed in hong kong shares. Goldman Sachs maintains its prediction for china life insurance's dividend per share this year at HKD 0.65, equivalent to a year-on-year growth of 51%, which implies a dividend yield of about 17% for this year. Based on a 30% dividend payout ratio, the forecasts for dividend per share for 2025 and 2026 have been slightly adjusted by 6% and 3%, respectively. Additionally, Goldman Sachs raised the new business value forecast for china life insurance for 2024 to 2026 by 6% to 10%, reflecting the better-than-expected expansion of profit margins so far this year, as well as the anticipated further decline in guaranteed policy returns in the fourth quarter of this year.